PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 135 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,329,568 | +26.8% | 446,400 | +5.6% | 1.96% | -11.0% |
| Q1 2023 | $9,724,400 | +155.5% | 422,800 | +163.1% | 2.21% | +341.2% |
| Q1 2022 | $3,806,000 | -12.3% | 160,700 | +26.6% | 0.50% | -22.7% |
| Q4 2021 | $4,341,000 | +300.8% | 126,900 | +107.7% | 0.65% | +751.3% |
| Q3 2021 | $1,083,000 | -3.0% | 61,100 | -61.4% | 0.08% | -9.5% |
| Q1 2020 | $1,117,000 | +102.4% | 158,222 | +102.0% | 0.08% | -5.6% |
| Q4 2019 | $552,000 | – | 78,326 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |